62nd ASH Annual Meeting and Exposition: 905. Outcomes Research—Malignant Conditions (Lymphoid Disease): Outcomes Research Real World Data Healthcare Disparities

Oral and Poster Abstracts
Oral

Adult, Follicular Lymphoma, multiple myeloma, Diseases, CLL, Lymphoma (any), Marginal Zone Lymphoma, Hodgkin Lymphoma, Elderly, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma, DLBCL, Hemoglobinopathies, immune cells, Plasma Cell Disorders, Cell Lineage, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, Quality Improvement

Moderators:

Lena E. Winestone, MD, MSHP, UCSF, University of California San Francisco, Benioff Children's Hospital and Narendranath Epperla, MD, MS, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Disclosures:

Epperla: Verastem Oncology: Speakers Bureau; Beigene: Speakers Bureau; Pharmacyclics: Honoraria.

12:00 PM

207

Patient Selection Bias Limits the Real World Efficacy of Randomized Clinical Trials in Multiple Myeloma

Augusta Eduafo, DO¹^*, Leland Metheny III, MD², James Driscoll³^*, Benjamin K. Tomlinson, MD², Kirsten M Boughan, DO², Molly M Gallogly, MD, PhD², Marcos de Lima, MD² and Ehsan Malek, MD⁴

¹Internal Medicine Department, St. John Medical Center, Cleveland, OH
²Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
³Case Western Reserve University, Cleveland, OH
⁴Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH

12:15 PM

208

Racial and Ethnic Disparities in the Survival of Patients with Indolent Non-Hodgkin Lymphoma in the United States: A Population-Based Analysis

John L Vaughn, MD¹, Ana C. Xavier, MD² and Narendranath Epperla, MD, MS³

¹Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY
²University of Alabama at Birmingham, Vestavia Hills, AL
³Department of Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH

12:30 PM

209

The Impact of Race and Ethnicity on Diffuse Large B-Cell Lymphoma (DLBCL) Outcomes within the Veterans Health Administration (VHA)

Madison H. Williams, MD^1,2, Ryan A. Williams, MD^2,3, Jean Pierre Blaize, MD^2,3, Snegha Ananth, MBBS^2,3, David Gregorio, DO^2,3, Gerardo Manuel Rosas, MD^2,3^*, Michael M. Song, MD, PhD, PharmD^2,3, Brian Warnecke, DO^2,3^*, Abhishek Pandya, DO^2,3, Lakene Raissa Djoufack Djoumessi, MD^2,3^*, Vivian Dee, NP²^*, Phillip Nazarewicz²^*, Kathleen Franklin²^*, Juan J. Toro, MD, MS²^*, Michael Mader, MS²^* and Zohra Nooruddin, MD²

¹University of Texas Health Science Center At San Antonio, San Antonio, TX
²South Texas Veterans Health Care System, San Antonio, TX
³University of Texas Health Science Center San Antonio, San Antonio, TX

12:45 PM

210

Hospitalization at the End of Life in Myeloma Patients: Lessons from the National Inpatient Sample

Saqib Abbasi, MD¹, Brian McClune²^*, Al-Ola Abdallah, MD³, Leyla Shune, MD³ and Ghulam Rehman Mohyuddin⁴^*

¹Kansas University Medical Center, Kansas City, KS
²University of Utah, Salt Lake City
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
⁴Kansas University Medical Center, Kansas City

1:00 PM

211

Disparities in Outcomes of Hospitalizations Due to Multiple Myeloma: A Nationwide Comparison

Siddharth Bhesania¹^*, Silpa Anand²^*, Tanveer Dabria³^*, Swathi Veliginti⁴^*, Sahithi Nadella⁵^*, Nikhil Kumar Kotla⁶^*, Pritika Manaktala, MD⁷^*, Chanoa Medina, MD¹^*, Janki Bhesania, MD⁸^*, Achint Patel, MD, MPH⁹^*, Angelica Singh, MD¹^*, Parag Mehta, MD¹^* and Eshan Patel, MD¹

¹NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY
²Swedish Covenant Hospital, Chicago, IL
³Gian Sagar Medical College & Hospital, Rajpura, India
⁴Shadan Institute Of Medical Sciences, Hyderabad, India
⁵Bhaskar Medical College & General Hospital, Hyderabad, India
⁶Kamineni Institute of Medical Sciences, Narketpally, India
⁷Canton Medical Education Foundation, Canton, OH
⁸Independent Researcher, Brooklyn
⁹Independent Researcher, Sayre, PA

1:15 PM

212

Role of Neutrophil Lymphocyte Ratio [NLR] As a Biomarker of Frailty and Predictor of Survival Among Older Adults with Multiple Myeloma (MM)

Smith Giri, MD¹, Susan Bal, MD, MBBS², Kelly N. Godby, MD¹^*, Joshua Richman, MD, PhD³^*, Adam J Olszewski, MD⁴, Grant R Williams⁵^*, Luciano J. Costa, MD, PhD⁶ and Smita Bhatia, MD, MPH⁵

¹University of Alabama at Birmingham, Birmingham, AL
²O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
³Institute for Cancer Outcomes and Survivorship, University of Alabama Birmingham, Birmingham, AL
⁴Brown University, Providence, RI
⁵Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
⁶Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL

See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

905.O3.6 905. Outcomes Research—Malignant Conditions (Lymphoid Disease): Outcomes Research Real World Data Healthcare Disparities